Search research articles
Contact Us
Filters
Showing results (271-280 of 340) with videos related to
Page
of 34
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2008
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
B Chauffert, F Mornex, F Bonnetain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 29, 2008
Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review
Oscar Matzinger, Philip Poortmans, Jean-Yves Giraud, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 12, 2011
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent
Jacques Tortochaux, Yungan Tao, Elodie Tournay, et al.
The Laryngoscope
|
May 31, 2022
Long-Term Outcomes in Head and Neck Paragangliomas Managed with Intensity-Modulated Radiotherapy
Guillaume Rougier, Adrien Rochand, Rémi Bourdais, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2000
Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results
P Bey, C Carrie, V Beckendorf, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
January 30, 2020
Dose distribution of the brain tissue associated with cognitive functions in high-grade glioma patients
J Jacob, E Clausse, M A Benadjaoud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2009
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)
O Matzinger, F Roelofsen, L Mineur, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 7, 2013
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]
B Chauvet, M-A Mahé, P Maingon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]
M Barhoumi, F Mornex, F Bonnetain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 26, 2025
ESTRO framework for radiation oncology departments to mitigate against cyberattacks
Samuel Peters, Anita O'Donovan, Marcello Bellini, et al.
Page
of 34
Search research articles
Search
Showing results (271-280 of 340) with videos related to
Sort By:
Page
of 34
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2008
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
B Chauffert, F Mornex, F Bonnetain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 29, 2008
Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review
Oscar Matzinger, Philip Poortmans, Jean-Yves Giraud, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 12, 2011
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent
Jacques Tortochaux, Yungan Tao, Elodie Tournay, et al.
The Laryngoscope
|
May 31, 2022
Long-Term Outcomes in Head and Neck Paragangliomas Managed with Intensity-Modulated Radiotherapy
Guillaume Rougier, Adrien Rochand, Rémi Bourdais, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2000
Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results
P Bey, C Carrie, V Beckendorf, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
January 30, 2020
Dose distribution of the brain tissue associated with cognitive functions in high-grade glioma patients
J Jacob, E Clausse, M A Benadjaoud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2009
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)
O Matzinger, F Roelofsen, L Mineur, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 7, 2013
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]
B Chauvet, M-A Mahé, P Maingon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]
M Barhoumi, F Mornex, F Bonnetain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 26, 2025
ESTRO framework for radiation oncology departments to mitigate against cyberattacks
Samuel Peters, Anita O'Donovan, Marcello Bellini, et al.
Page
of 34